UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) Comparison with companies in other sectors?

UBS CMCI Composite SF UCITS ETF USD acc has a share price of 16.77M. You can analyze UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) competitors across different market sectors through stock heatmaps.

What are UIQK.DE's NET and operating margins?

UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does UIQK.DE's earnings per share (EPS) trend reflect its financial momentum?

UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) EPS is N/A (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for UBS CMCI Composite SF UCITS ETF USD acc is N/A, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for UBS CMCI Composite SF UCITS ETF USD acc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for UBS CMCI Composite SF UCITS ETF USD acc like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

UBS CMCI Composite SF UCITS ETF USD acc

UIQK.DE•XETRA

Financial Services

Asset Management

€119.50

€-0.66(-0.55%)

German Market opens in 37h 16m

UBS CMCI Composite SF UCITS ETF USD acc Fundamental Analysis

UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze UIQK.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze UIQK.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

UIQK.DE struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

UIQK.DE trades at a premium to fair value.

PE < 25

N/A

PEG Ratio < 2

N/A

Growth Score

Weak

UIQK.DE faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

UIQK.DE carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

UIQK.DE struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is UIQK.DE Expensive or Cheap?

No data available.

How Well Does UIQK.DE Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How UIQK.DE Stacks Against Its Sector Peers

Metric	UIQK.DE Value	Sector Average	Performance
P/E Ratio	N/A	19.04	N/A
ROE	N/A	808.00%	N/A
Net Margin	N/A	-7820.00% (disorted)	N/A
Debt/Equity	N/A	1.00	N/A
Current Ratio	N/A	611.26	N/A
ROA	N/A	-23985.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews UBS CMCI Composite SF UCITS ETF USD acc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

UBS CMCI Composite SF UCITS ETF USD acc Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is UIQK.DE Expensive or Cheap?

How Well Does UIQK.DE Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How UIQK.DE Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

UBS CMCI Composite SF UCITS ETF USD acc (UIQK.DE) Comparison with companies in other sectors?

What are UIQK.DE's NET and operating margins?

In what way does UIQK.DE's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for UBS CMCI Composite SF UCITS ETF USD acc?

How do I know if AAPL is overvalued or undervalued?